Are older adults more likely to have heart rhythm problems with lacosamide?
The provided information does not include data on whether elderly people are more susceptible to lacosamide-related arrhythmias, or how risk changes with age.
Does age change lacosamide’s heart-safety risk (PR/QRS, atrioventricular block)?
The provided information also does not include age-stratified findings (for example, rates of PR-interval prolongation, atrioventricular block, or other conduction abnormalities) in lacosamide users. Without those data, it is not possible to state whether older adults face a higher arrhythmia risk from lacosamide.
What else (besides age) might increase lacosamide arrhythmia risk?
The provided information does not specify lacosamide risk factors for arrhythmia. In general clinical practice, conduction issues can be influenced by factors like underlying cardiac disease and interacting drugs, but this cannot be confirmed here for lacosamide specifically.
Bottom line
Based on the information available here, there is no evidence provided that directly answers whether elderly patients are more susceptible to lacosamide-associated arrhythmias.
If you want, share what “provided information” you’re referring to
If you paste the excerpt (e.g., from a label, study, or guideline) or tell me the document/source name, I can extract the relevant age-related findings and summarize them accurately.